Supplements for brain health show no benefit
In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.
In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.
In a new eLife article, UF neuroscientists examine brain mechanisms involved with the ability to delay gratification in older and younger adults.
In the journal Neuron, Dr. Golde highlights the promise and challenges of a possible path to treat Alzheimer’s disease and other neurodegenerative disorders.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
The MBI and UF departments of neuroscience and psychiatry co-sponsored the 9th annual North Central Florida Chapter of the Society for Neuroscience Conference.
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
A new study led by Drs. Sara Burke and Abbi Hernandez showed that implementing a ketogenic diet even late in life may be beneficial for improving cognitive outcomes.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Retired Col. Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.